Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Association between CD14 promoter -159C/T polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis.

Zhang AQ, Yue CL, Gu W, Du J, Wang HY, Jiang J.

PLoS One. 2013 Aug 19;8(8):e71237. doi: 10.1371/journal.pone.0071237. eCollection 2013. Review.

2.

Association of CD14 gene -159C/T polymorphism with allergic rhinitis risk: a meta-analysis.

Xu Y, Wang J.

Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1601-7. doi: 10.1007/s00405-013-2793-5. Epub 2013 Oct 30.

PMID:
24170183
3.

The -159C/T polymorphism in the CD14 gene and cancer risk: a meta-analysis.

Zhou W, Jia L, Guo S, Hu Q, Shen Y, Li N.

Onco Targets Ther. 2013 Dec 10;7:5-12. doi: 10.2147/OTT.S54547. eCollection 2013.

4.

The -159C/T polymorphism in the CD14 gene and tuberculosis risk: a meta-analysis.

Wang T, Shen Y, Chen L, Guo S, Jia L, Yang T, An J, Wen F.

Int J Med Sci. 2013 Aug 31;10(11):1524-9. doi: 10.7150/ijms.6376. eCollection 2013.

5.

Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis.

Zeng T, Zhang CL, Han XY, Zhao S, Xie KQ.

Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1183-9. doi: 10.1097/MEG.0b013e3283612ff1.

PMID:
23587862
6.

Contribution of CD14-159C/T polymorphism to tuberculosis susceptibility: a meta-analysis.

Zhao J, Lin G, Zhang WH, Ge M, Zhang Y.

Int J Tuberc Lung Dis. 2013 Nov;17(11):1472-8. doi: 10.5588/ijtld.13.0264. Review.

PMID:
24125453
7.

The -159C/T polymorphism in the CD14 gene and the risk of asthma: a meta-analysis.

Zhang Y, Tian C, Zhang J, Li X, Wan H, He C, Guo L, Meilang Q, Peng C, Duo L, Huang J, Fan H.

Immunogenetics. 2011 Jan;63(1):23-32. doi: 10.1007/s00251-010-0489-1. Epub 2010 Nov 16.

PMID:
21079949
8.

The CD14--159C/T polymorphisms and the risks of tuberculosis: a meta-analysis.

Guo FF, Xie Q, An RF, Zeng T, Zhou W.

Infect Genet Evol. 2013 Aug;18:277-83. doi: 10.1016/j.meegid.2013.06.001. Epub 2013 Jun 12.

PMID:
23770267
9.

CD14 -159 C>T gene polymorphism with increased risk of tuberculosis: evidence from a meta-analysis.

Areeshi MY, Mandal RK, Panda AK, Bisht SC, Haque S.

PLoS One. 2013 May 31;8(5):e64747. doi: 10.1371/journal.pone.0064747. Print 2013.

10.

[Distribution and clinical significance of CD14 promoter-159C/T polymorphism in patients with extensive burn].

Dong N, Yao YM, Yu Y, Cao YJ, Sheng ZY.

Zhonghua Shao Shang Za Zhi. 2009 Apr;25(2):115-8. Chinese.

PMID:
19799036
11.

CD14 -159C/T polymorphism contributes to the susceptibility to tuberculosis: evidence from pooled 1,700 cases and 1,816 controls.

Miao R, Ge H, Xu L, Xu F.

Mol Biol Rep. 2014 May;41(5):3481-6. doi: 10.1007/s11033-014-3210-x. Epub 2014 Feb 12.

PMID:
24519436
12.

Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis.

Teuffel O, Ethier MC, Beyene J, Sung L.

Crit Care Med. 2010 Jan;38(1):276-82. doi: 10.1097/CCM.0b013e3181b42af0. Review.

PMID:
19789454
13.

No Association Between -159C/T Polymorphism of the CD14 Gene and Asthma Risk: a Meta-Analysis of 36 Case-Control Studies.

Zhang R, Deng R, Li H, Chen H.

Inflammation. 2015 Oct 13. [Epub ahead of print]

PMID:
26463530
14.

The association between CD14-260C/T polymorphism and malignant tumor risk: a meta-analysis of 5,603 participants.

Tong X, Li Z, Fu X, Zhou K, Wu Y, Zhang Y, Fan H.

Tumour Biol. 2014 Sep;35(9):8707-13. doi: 10.1007/s13277-014-2040-8. Epub 2014 May 29.

PMID:
24870592
15.

Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis.

Zhang AQ, Pan W, Gao JW, Yue CL, Zeng L, Gu W, Jiang JX.

BMC Med Genet. 2014 Jan 16;15:8. doi: 10.1186/1471-2350-15-8.

16.

Failure to find an association between CD14-159C/T polymorphism and asthma: a family-based association test and meta-analysis.

Nishimura F, Shibasaki M, Ichikawa K, Arinami T, Noguchi E.

Allergol Int. 2006 Mar;55(1):55-8.

17.

[The influence of CD14 genomic polymorphism on CD14 gene expression as well as protein release and its clinical significance in patients with extensive burns].

Lin J, Yao YM, Huang ZH, Yu Y, Zhu JM, Chai JK, Sheng ZY.

Zhonghua Wai Ke Za Zhi. 2006 Jul 1;44(13):907-10. Chinese.

PMID:
17067484
18.

Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis.

Wang Z, Hu J, Fan R, Zhou J, Zhong J.

PLoS One. 2012;7(9):e45144. doi: 10.1371/journal.pone.0045144. Epub 2012 Sep 26.

19.

CD14 gene-159C/T polymorphism and coronary artery disease: a meta-analysis involving 4467 subjects.

Li YY, Wang XM, Zhou CW, Xu J, Qian Y.

Int J Clin Exp Med. 2015 Aug 15;8(8):12149-60. eCollection 2015.

20.

CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.

Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann H.

Thorac Cardiovasc Surg. 2009 Oct;57(7):386-90. doi: 10.1055/s-0029-1185876. Epub 2009 Sep 30.

PMID:
19795323
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk